Literature DB >> 18393456

A concentration-dependent analysis method for high density protein microarrays.

Ovidiu Marina1, Melinda A Biernacki, Vladimir Brusic, Catherine J Wu.   

Abstract

Protein microarray technology is rapidly growing and has the potential to accelerate the discovery of targets of serum antibody responses in cancer, autoimmunity and infectious disease. Analytical tools for interpreting this high-throughput array data, however, are not well-established. We developed a concentration-dependent analysis (CDA) method which normalizes protein microarray data based on the concentration of spotted probes. We show that this analysis samples a data space that is complementary to other commonly employed analyses, and demonstrate experimental validation of 92% of hits identified by the intersection of CDA with other tools. These data support the use of CDA either as a preprocessing step for a more complete proteomic microarray data analysis or as a stand-alone analysis method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393456     DOI: 10.1021/pr700892h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  8 in total

1.  Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.

Authors:  Fabrice Porcheray; Julie DeVito; Beow Y Yeap; Lijuan Xue; Ian Dargon; Rosemary Paine; Timothy C Girouard; Susan L Saidman; Robert B Colvin; Waichi Wong; Emmanuel Zorn
Journal:  Transplantation       Date:  2010-05-27       Impact factor: 4.939

2.  Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantation.

Authors:  Melinda A Biernacki; Yu-tzu Tai; Guang Lan Zhang; Anselmo Alonso; Wandi Zhang; Rao Prabhala; Li Zhang; Nikhil Munshi; Donna Neuberg; Robert J Soiffer; Jerome Ritz; Edwin P Alyea; Vladimir Brusic; Kenneth C Anderson; Catherine J Wu
Journal:  Blood       Date:  2012-01-20       Impact factor: 22.113

Review 3.  Defining the humoral immune response to infectious agents using high-density protein microarrays.

Authors:  Adam Vigil; D Huw Davies; Philip L Felgner
Journal:  Future Microbiol       Date:  2010-02       Impact factor: 3.165

4.  Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.

Authors:  Ovidiu Marina; Ursula Hainz; Melinda A Biernacki; Wandi Zhang; Ann Cai; Jonathan S Duke-Cohan; Fenglong Liu; Vladimir Brusic; Donna Neuberg; Jeffery L Kutok; Edwin P Alyea; Christine M Canning; Robert J Soiffer; Jerome Ritz; Catherine J Wu
Journal:  Cancer Res       Date:  2010-02-02       Impact factor: 12.701

5.  B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans.

Authors:  F Porcheray; W Wong; S L Saidman; J De Vito; T C Girouard; M Chittenden; J Shaffer; N Tolkoff-Rubin; B R Dey; T R Spitzer; R B Colvin; A B Cosimi; T Kawai; D H Sachs; M Sykes; E Zorn
Journal:  Am J Transplant       Date:  2009-07-16       Impact factor: 8.086

6.  Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells.

Authors:  Melinda A Biernacki; Ovidiu Marina; Wandi Zhang; Fenglong Liu; Ingmar Bruns; Ann Cai; Donna Neuberg; Christine M Canning; Edwin P Alyea; Robert J Soiffer; Vladimir Brusic; Jerome Ritz; Catherine J Wu
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

Review 7.  Protein microarrays and biomarkers of infectious disease.

Authors:  Mohan Natesan; Robert G Ulrich
Journal:  Int J Mol Sci       Date:  2010-12-16       Impact factor: 5.923

8.  PMA: Protein Microarray Analyser, a user-friendly tool for data processing and normalization.

Authors:  Jessica Da Gama Duarte; Ryan W Goosen; Peter J Lawry; Jonathan M Blackburn
Journal:  BMC Res Notes       Date:  2018-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.